Skip to main content
Kangmei Pharmaceutical Co.,Ltd logo

Kangmei Pharmaceutical Co.,Ltd — Investor Relations & Filings

Ticker · 600518 ISIN · CNE0000017M1 LEI · 3003006FRNBUUTVKBB50 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,369 across all filing types
Latest filing 2026-03-20 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600518

About Kangmei Pharmaceutical Co.,Ltd

http://www.kangmei.com.cn

Kangmei Pharmaceutical Co.,Ltd. focuses on the research, development, production, and distribution of Traditional Chinese Medicine (TCM). The company manages an integrated industry chain that includes herbal cultivation, standardized processing of decoction pieces, and the manufacturing of patent medicines. Its offerings extend to health supplements, medical devices, and functional foods. A key component of its operations is the management of large-scale TCM trading centers and logistics hubs designed to standardize the trade of medicinal materials. Through its "Internet + Healthcare" initiatives, the company provides digital health management and pharmaceutical supply chain services, catering to medical institutions, retail pharmacies, and individual consumers.

Recent filings

Filing Released Lang Actions
康美药业关于全资子公司补缴税款的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Kangmei Pharmaceutical Co., Ltd. regarding a tax payment by its wholly-owned subsidiary. It details the tax authority's decision for the subsidiary to pay additional corporate income tax and related late fees for the years 2020 to 2024. The announcement includes the impact on the company's future net profit and clarifies that this is not a financial report but a regulatory disclosure about tax matters. The document is short (651 characters) and serves as a formal public announcement of a tax-related event, not a financial report or audit. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2026-03-20 Chinese
康美药业关于变更签字注册会计师及项目质量控制复核合伙人的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from 康美药业股份有限公司 regarding the change of signing certified public accountants and project quality control review partners for the company's 2025 financial report and internal control audit. It details the personnel changes, their qualifications, and confirms that the changes will not adversely affect the audit work. The document is short (1104 characters) and serves as a formal announcement about auditor personnel changes rather than the audit report itself. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related audit information such as changes in auditors or audit partners. It is not a full annual report or financial statement, nor is it a mere publication announcement or regulatory filing. Therefore, the correct classification is AR with high confidence. FY 2025
2026-01-09 Chinese
康美药业关于补选董事会专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a new member to the company's board specialized committees. It details the appointment of a director to the audit and nomination committees and provides the updated composition of these committees. There is no financial data, no report attached or referenced, and the content focuses on board/management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is a formal announcement of a board committee change, not a full report or other filing type.
2026-01-05 Chinese
康美药业第十届董事会2026年度第一次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of a board meeting resolution by 康美药业股份有限公司 (Kangmei Pharmaceutical Co., Ltd.) regarding the election of a committee member to the 10th Board of Directors. It includes details about the meeting date, attendance, and voting results. There is no financial data, audit information, or report content. The document is clearly about board/management information, specifically changes or updates related to the board's composition. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on a board resolution, not a full report or announcement of a report publication.
2026-01-05 Chinese
康美药业2025年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 second extraordinary general meeting of shareholders of Kangmei Pharmaceutical Co., Ltd. It includes information about the meeting date, location, attendance, voting results on multiple proposals, and legal witness statements. The content focuses on the voting outcomes and procedural compliance of the shareholders' meeting. There is no financial data, earnings information, or management discussion of financial results. The document is not a report itself but an official announcement of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is over 6000 characters, indicating it is a full announcement rather than a brief notice or a report publication announcement.
2025-12-26 Chinese
广东信达律师事务所关于康美药业股份有限公司2025年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 84% confidence The document is a legal opinion (“法律意见书”) issued by a law firm regarding the convening, attendance qualifications, and detailed vote results for the company’s 2025 second extraordinary shareholders’ meeting. It is not an annual report, earnings release, or proxy solicitation, but rather an announcement and certification of voting results at a general meeting (EGM). Therefore it best fits the “Declaration of Voting Results & Voting Rights Announcements” category (DVA).
2025-12-26 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.